Logo image of STUD.CA

STALLION URANIUM CORP (STUD.CA) Stock Fundamental Analysis

TSX-V:STUD - TSX Venture Exchange - CA8529192087 - Common Stock - Currency: CAD

0.13  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to STUD. STUD was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. While STUD seems to be doing ok healthwise, there are quite some concerns on its profitability. STUD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year STUD has reported negative net income.
STUD had a negative operating cash flow in the past year.
STUD had negative earnings in each of the past 5 years.
In the past 5 years STUD always reported negative operating cash flow.
STUD.CA Yearly Net Income VS EBIT VS OCF VS FCFSTUD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

STUD's Return On Assets of -12.12% is on the low side compared to the rest of the industry. STUD is outperformed by 66.35% of its industry peers.
With a Return On Equity value of -13.22%, STUD is not doing good in the industry: 63.03% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -12.12%
ROE -13.22%
ROIC N/A
ROA(3y)-7.07%
ROA(5y)-14.87%
ROE(3y)-7.27%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STUD.CA Yearly ROA, ROE, ROICSTUD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for STUD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STUD.CA Yearly Profit, Operating, Gross MarginsSTUD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

4

2. Health

2.1 Basic Checks

The number of shares outstanding for STUD has been increased compared to 1 year ago.
The number of shares outstanding for STUD has been increased compared to 5 years ago.
STUD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STUD.CA Yearly Shares OutstandingSTUD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
STUD.CA Yearly Total Debt VS Total AssetsSTUD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

STUD has an Altman-Z score of 0.04. This is a bad value and indicates that STUD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.04, STUD is doing worse than 67.77% of the companies in the same industry.
There is no outstanding debt for STUD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.04
ROIC/WACCN/A
WACCN/A
STUD.CA Yearly LT Debt VS Equity VS FCFSTUD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

STUD has a Current Ratio of 0.66. This is a bad value and indicates that STUD is not financially healthy enough and could expect problems in meeting its short term obligations.
STUD has a Current ratio of 0.66. This is comparable to the rest of the industry: STUD outperforms 48.34% of its industry peers.
STUD has a Quick Ratio of 0.66. This is a bad value and indicates that STUD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.66, STUD is in line with its industry, outperforming 50.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
STUD.CA Yearly Current Assets VS Current LiabilitesSTUD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

0

3. Growth

3.1 Past

STUD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -448.76%.
EPS 1Y (TTM)-448.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-314.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STUD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STUD.CA Price Earnings VS Forward Price EarningsSTUD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STUD.CA Per share dataSTUD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for STUD!.
Industry RankSector Rank
Dividend Yield N/A

STALLION URANIUM CORP

TSX-V:STUD (4/23/2025, 7:00:00 PM)

0.13

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.91%
Inst Owner ChangeN/A
Ins Owners1.15%
Ins Owner ChangeN/A
Market Cap3.94M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS0.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.12%
ROE -13.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.07%
ROA(5y)-14.87%
ROE(3y)-7.27%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 0.04
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-448.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-314.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-137.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-507.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-505.98%
OCF growth 3YN/A
OCF growth 5YN/A